4//SEC Filing
Orexigen Therapeutics, Inc. 4
Accession 0001209191-17-037332
CIK 0001382911operating
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:47 PM ET
Size
4.7 KB
Accession
0001209191-17-037332
Insider Transaction Report
Form 4
Lynch Thomas P.
EVP. General Counsel & Sec.
Transactions
- Award
Common Stock
2017-05-31$1.55/sh+1,704$2,641→ 1,704 total
Footnotes (1)
- [F1]Shares acquired under Issuer's 2013 Employee Stock Purchase Plan.
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001382911
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:47 PM ET
- Size
- 4.7 KB